Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function?
Background: Hyperlipidemia is a common problem after kidney transplantation.Objective: To uncover the real impact of post kidney transplantation hyperlipidemia on graft function and survival, and to determine whether it is just a biochemical phenomenon after using immunosuppressant or a part of dise...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2010-07-01
|
Series: | International Journal of Organ Transplantation Medicine |
Subjects: | |
Online Access: | http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/39/76 |
_version_ | 1828491332134371328 |
---|---|
author | G. Pourmand A. Saraji S. Dehgani A. Mehrsai M. Nikoobakht M. Talibnajad E. Razeghi M. Rahbar H. Hosseini N. Pourmand Sh. Pourmand M. Zahedikia M. Porhussein F. Heidari |
author_facet | G. Pourmand A. Saraji S. Dehgani A. Mehrsai M. Nikoobakht M. Talibnajad E. Razeghi M. Rahbar H. Hosseini N. Pourmand Sh. Pourmand M. Zahedikia M. Porhussein F. Heidari |
author_sort | G. Pourmand |
collection | DOAJ |
description | Background: Hyperlipidemia is a common problem after kidney transplantation.Objective: To uncover the real impact of post kidney transplantation hyperlipidemia on graft function and survival, and to determine whether it is just a biochemical phenomenon after using immunosuppressant or a part of disease pathology.Methods: 330 kidney transplants were managed in Sina Hospital Kidney Transplantation Unit affiliated to Tehran University of Medical Sciences, Tehran, Iran from September 1994 till February 2010. The demographiccharacteristics of the patients, causes of chronic kidney diseases, history of pretransplantation dialysis, pretransplantation comorbidities (e.g., hypertension, diabetes mellitus [DM], hyperlipidemia and coronary artery disease), rejection episodes, status of infection with cytomegalous virus [CMV], post-transplantationDM, hyperlipidemia, ischemic heart disease [IHD], and graft and patient survival were recorded. A serum creatinine level >2 mg/dL was considered as “graft deterioration,” and return to dialysis as “graft loss.” According to the presence or absence of post kidney transplantation hypercholesterolemia (>200 mg/dL) or hypertriglyceridemia (>200 mg/dL), the patients were classified into “hyperlipidemic” or “non-hyperlipidemic.”The presence of clinical or paraclinical coronary artery disease was also determined in both groups.Results: The incidence of hyperlipidemia elevated from 8% to 50% before and after transplantation. 2.7% developed clinical IHD. 13% of hyperlipidemics and 22% of non-hyperlipidemics developed graft deterioration.Among hyperlipidemics with deteriorated grafts 40% had premorbid diseases, 68% had CMV infectionand 82% had hypertension. Only 22% had previous acute rejection and 27% received deceased kidney transplant.Conclusions: post kidney transplantation hyperlipidemia is just an associated phenomenon secondary to the use of immunosuppressant medications, which have no obvious impact on renal graft function and can be easily controlled by instituting dietary modifications and use of modern antilipid medications. Post kidneytransplantation CMV infection and hypertension are considered as the main threatening risk for renal graft—even more dangerous than acute or chronic rejections. |
first_indexed | 2024-12-11T11:00:28Z |
format | Article |
id | doaj.art-23c6bf8c787b455f91cf538151c3cc59 |
institution | Directory Open Access Journal |
issn | 2008-6490 2008-6482 |
language | English |
last_indexed | 2024-12-11T11:00:28Z |
publishDate | 2010-07-01 |
publisher | Shiraz University of Medical Sciences |
record_format | Article |
series | International Journal of Organ Transplantation Medicine |
spelling | doaj.art-23c6bf8c787b455f91cf538151c3cc592022-12-22T01:09:54ZengShiraz University of Medical SciencesInternational Journal of Organ Transplantation Medicine2008-64902008-64822010-07-0113131137Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function?G. PourmandA. SarajiS. DehganiA. MehrsaiM. NikoobakhtM. TalibnajadE. RazeghiM. RahbarH. HosseiniN. PourmandSh. PourmandM. ZahedikiaM. PorhusseinF. HeidariBackground: Hyperlipidemia is a common problem after kidney transplantation.Objective: To uncover the real impact of post kidney transplantation hyperlipidemia on graft function and survival, and to determine whether it is just a biochemical phenomenon after using immunosuppressant or a part of disease pathology.Methods: 330 kidney transplants were managed in Sina Hospital Kidney Transplantation Unit affiliated to Tehran University of Medical Sciences, Tehran, Iran from September 1994 till February 2010. The demographiccharacteristics of the patients, causes of chronic kidney diseases, history of pretransplantation dialysis, pretransplantation comorbidities (e.g., hypertension, diabetes mellitus [DM], hyperlipidemia and coronary artery disease), rejection episodes, status of infection with cytomegalous virus [CMV], post-transplantationDM, hyperlipidemia, ischemic heart disease [IHD], and graft and patient survival were recorded. A serum creatinine level >2 mg/dL was considered as “graft deterioration,” and return to dialysis as “graft loss.” According to the presence or absence of post kidney transplantation hypercholesterolemia (>200 mg/dL) or hypertriglyceridemia (>200 mg/dL), the patients were classified into “hyperlipidemic” or “non-hyperlipidemic.”The presence of clinical or paraclinical coronary artery disease was also determined in both groups.Results: The incidence of hyperlipidemia elevated from 8% to 50% before and after transplantation. 2.7% developed clinical IHD. 13% of hyperlipidemics and 22% of non-hyperlipidemics developed graft deterioration.Among hyperlipidemics with deteriorated grafts 40% had premorbid diseases, 68% had CMV infectionand 82% had hypertension. Only 22% had previous acute rejection and 27% received deceased kidney transplant.Conclusions: post kidney transplantation hyperlipidemia is just an associated phenomenon secondary to the use of immunosuppressant medications, which have no obvious impact on renal graft function and can be easily controlled by instituting dietary modifications and use of modern antilipid medications. Post kidneytransplantation CMV infection and hypertension are considered as the main threatening risk for renal graft—even more dangerous than acute or chronic rejections.http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/39/76HyperlipidemiaPost kidney transplantationGrafts survival |
spellingShingle | G. Pourmand A. Saraji S. Dehgani A. Mehrsai M. Nikoobakht M. Talibnajad E. Razeghi M. Rahbar H. Hosseini N. Pourmand Sh. Pourmand M. Zahedikia M. Porhussein F. Heidari Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function? International Journal of Organ Transplantation Medicine Hyperlipidemia Post kidney transplantation Grafts survival |
title | Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function? |
title_full | Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function? |
title_fullStr | Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function? |
title_full_unstemmed | Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function? |
title_short | Should Post Kidney Transplantation Hyperlipidemia Considered a Risk Factor for Graft Function? |
title_sort | should post kidney transplantation hyperlipidemia considered a risk factor for graft function |
topic | Hyperlipidemia Post kidney transplantation Grafts survival |
url | http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/39/76 |
work_keys_str_mv | AT gpourmand shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT asaraji shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT sdehgani shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT amehrsai shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT mnikoobakht shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT mtalibnajad shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT erazeghi shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT mrahbar shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT hhosseini shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT npourmand shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT shpourmand shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT mzahedikia shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT mporhussein shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction AT fheidari shouldpostkidneytransplantationhyperlipidemiaconsideredariskfactorforgraftfunction |